Roger J Hajjar

MD Icahn School of Medicine at Mount Sinai, New York, NY, USA


Dr Hajjar is the Director of the Cardiovascular Research Center and the Arthur and Janet C Ross Professor of Medicine at the Mount Sinai School of Medicine. His research focuses on molecular mechanisms of heart failure (HF) and his team has validated the cardiac sarcoplasmic reticulum calcium ATPase pump (SERCA2a) as a target in HF, developed methodologies for cardiac-directed gene therapy, examined the functional consequences of SERCA2a gene transfer in the failing heart, and conducted first-in-man clinical trials testing the efficacy of gene transfer in patients with HF. Dr Hajjar is a founding member of the A-CURE Working Group.


A33 - Improving the Gene Transduction Efficacy of Intracoronary Delivery Using the Impella

Serena Tharakan, Taro Kariya, Olympia Bikou, et al


Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A33.

Impella Support and Cardiac Gene Therapy for Heart Failure

Roger J Hajjar,


Citation: Interventional Cardiology Review 2017;12(2 Suppl 2):9-10.